All Moffitt Cancer Center articles
-
News
Gut microbiome influences how lymphoma patients respond to CAR T therapy
Study finds antibiotic treatment and different types of microorganisms can impact chimeric antigen receptor T-cell therapy outcomes.
-
News
Viruses that kill cancer cells show promise for triple-negative breast cancer when combined with chemo
Researchers have shared positive results from a phase 2 clinical trial of an oncolytic virus combined with standard chemotherapy in patients with early stage triple-negative breast cancer.